These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7497714)

  • 1. A new approach to affective symptoms in relapsing-remitting multiple sclerosis.
    Noy S; Achiron A; Gabbay U; Barak Y; Rotstein Z; Laor N; Sarova-Pinhas I
    Compr Psychiatry; 1995; 36(5):390-5. PubMed ID: 7497714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia.
    Fortune DG; Richards HL; Griffiths CE; Main CJ
    Br J Clin Psychol; 2002 Jun; 41(Pt 2):157-74. PubMed ID: 12034003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-sectional study of alexithymia in patients with relapse remitting form of multiple sclerosis.
    Stojanov J; Stojanov A
    J Postgrad Med; 2020; 66(1):23-27. PubMed ID: 31929308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anxiety and physical limitation: a complex relation].
    Léger E; Ladouceur R; Freeston MH
    Encephale; 2002; 28(3 Pt 1):205-9. PubMed ID: 12091780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis.
    Tan-Kristanto S; Kiropoulos LA
    Psychol Health Med; 2015; 20(6):635-45. PubMed ID: 25588098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of mood and affect in schizophrenic inpatients.
    Craig TJ; Richardson MA; Pass R; Bregman Z
    Am J Psychiatry; 1985 Nov; 142(11):1272-7. PubMed ID: 4061685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis.
    Möller A; Wiedemann G; Rohde U; Backmund H; Sonntag A
    Acta Psychiatr Scand; 1994 Feb; 89(2):117-21. PubMed ID: 8178661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with perceived need for mental health care in multiple sclerosis.
    Orr J; Bernstein CN; Graff LA; Patten SB; Bolton JM; Sareen J; Marriott JJ; Fisk JD; Marrie RA;
    Mult Scler Relat Disord; 2018 Oct; 25():179-185. PubMed ID: 30096684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resilience and depression/anxiety symptoms in multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakazawa K; Noda T; Ichikura K; Okamoto T; Takahashi Y; Yamamura T; Nakagome K
    Mult Scler Relat Disord; 2018 Oct; 25():309-315. PubMed ID: 30176401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment.
    Labiano-Fontcuberta A; Mitchell AJ; Moreno-García S; Benito-León J
    J Neurol Sci; 2015 Feb; 349(1-2):220-5. PubMed ID: 25638658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceived behavioral changes in early multiple sclerosis.
    Lima FS; Simioni S; Bruggimann L; Ruffieux C; Dudler J; Felley C; Michetti P; Annoni JM; Schluep M
    Behav Neurol; 2007; 18(2):81-90. PubMed ID: 17538194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Depression in relapsing-remitting multiple sclerosis].
    Mendes MF; Tilbery CP; Balsimelli S; Moreira MA; Barão-Cruz AM
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):591-5. PubMed ID: 14513163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychological evaluation and psychopathology of multiple sclerosis].
    Defer G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1128-34. PubMed ID: 11787345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disability status, disease parameters, defense styles, and ego strength associated with psychiatric complications of multiple sclerosis.
    Hyphantis TN; Christou K; Kontoudaki S; Mantas C; Papamichael G; Goulia P; Konitsiotis S; Mavreas V
    Int J Psychiatry Med; 2008; 38(3):307-27. PubMed ID: 19069575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimensions of alexithymia and their relationships to anxiety and depression.
    Hendryx MS; Haviland MG; Shaw DG
    J Pers Assess; 1991 Apr; 56(2):227-37. PubMed ID: 2056418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric symptoms in patients with multiple sclerosis.
    Sarısoy G; Terzi M; Gümüş K; Pazvantoğlu O
    Gen Hosp Psychiatry; 2013; 35(2):134-40. PubMed ID: 23260339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression during multiple sclerosis relapse: relation to disability and relapse severity.
    Šabanagić-Hajrić S; Suljić E; Sulejmanpašić-Arslanagić G
    Med Glas (Zenica); 2016 Feb; 13(1):44-9. PubMed ID: 26827706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population.
    Lester K; Stepleman L; Hughes M
    J Behav Med; 2007 Apr; 30(2):177-86. PubMed ID: 17318458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of disease severity, depression and negative affectivity to fatigue in multiple sclerosis: a comparison with ulcerative colitis.
    Bol Y; Duits AA; Vertommen-Mertens CE; Hupperts RM; Romberg-Camps MJ; Verhey FR; Vlaeyen JW
    J Psychosom Res; 2010 Jul; 69(1):43-9. PubMed ID: 20630262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.